Rising Demands for Novel Small Molecules, Bio-Therapeutic and Cell Based Therapies and Increasing Incidence of Chronic Diseases are Expected to Drive the Global Cell-Based Assays Market in the forecast period of 2019 - 2026

Global Cell-Based Assays Market is projected to register a substantial CAGR of 8.7% in the forecast period 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Cell-Based Assays Market

Access Full Report at https://www.databridgemarketresearch.com/reports/global-cell-based-assays-market

DriversGlobal Cell-Based Assays Market

  • Rising demands for novel small molecules, bio-therapeutic and cell based therapies
  • Increase in research and development expenditure


  • Stringent regulatory requirements


  • Strategic initiative by the market players


  • Challenging analysis procedure

Market Trends:

Global cell based assays market is segmented into six notable segments which are on the basis of type, product and services, technology, application, end user and distribution channel.

  • On the basis of type, the market is segmented into cell viability assay, cell proliferation assay, cytotoxicity assay, cell death assay, others. In 2019, cell viability assay segment is expected to dominate the market with largest market share because cell viability assay helps in measuring the ongoing cellular metabolism and enzyme activity, by measuring different factors which is able to reflect the number of living cells in a population
  • On the basis of product and services, the market is segmented consumables, services, instruments and software.
  • On the basis of technology, the market is segmented into flow cytometry, label free detection, high content screening, high throughput screening.
  • On the basis of application, the market is segmented into drug discovery, basic research, others. In 2019, drug discovery segment is expected to dominate the market with largest market share due to increased R&D investment by the biopharmaceutical companies.
  • On the basis of end-user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutions, contract research organizations, government organizations and others.
  • On the basis of distribution channel, the market is segmented into direct and indirect.  In 2019, direct segment is expected to dominate the market with largest market share due to increasing cellular products and services supply directly from manufacturer as well as manufacturer find more profit by direct supply of cellular products and services.

Major Players: Global Cell-Based Assays Market

Some of the major players operating in the global cell based assays market are GENERAL ELECTRIC, Danaher, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories, Inc., ATCC, Aurelia Bioscience Ltd, BD, BioAgilytix Labs, BioVision Inc., Cell Signaling Technology, Inc, Cisbio, Enzo Biochem Inc., Eurofins Scientific, LakePharma, Inc., Lonza, Miltenyi Biotec, XenoDiagnostics, LLC and others.